<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01612364</url>
  </required_header>
  <id_info>
    <org_study_id>5138 - 1805142/1</org_study_id>
    <nct_id>NCT01612364</nct_id>
  </id_info>
  <brief_title>RCT :Thoracic Sympathetic Block for the Treatment of Complex Regional Pain Syndrome I of the Upper Limb</brief_title>
  <official_title>Double-Blind Randomized Controlled Trial: Thoracic Sympathetic Block for the Treatment of Complex Regional Pain Syndrome I of the Upper Limb</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double-blind randomized controlled trial to evaluate the efficacy of the
      sympathetic block via thoracic vertebra T3 for the treatment of CRPS I upper limb. Patients
      with CRPS I refractory to medical treatment will be subjected to four physical therapy
      sessions and then the randomized for experimental or control block and then more four
      physiotherapy sessions. Patients will be evaluated after one month of the blockade (primary
      outcome) and then up to 12 months. Will be evaluated by analgesic scale (Mcgill, brief pain
      inventory, dn4 questionnaire, NPSI, VAS), functional (ADM) and quality of life (HAD and
      WHOQOL-brief).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">November 2013</completion_date>
  <primary_completion_date type="Anticipated">November 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analgesia after block</measure>
    <time_frame>1 month</time_frame>
    <description>Analgesia (Mcgill, brief pain inventary, DN4 questionaire, VAS) and functional (ADM) evaluation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>analgesia quality of life</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Complex Regional Pain Syndrome I of Upper Limb</condition>
  <arm_group>
    <arm_group_label>thoracic sympathetic block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sympathetic block of upper limb via thoracic vertebra T3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Same medication used in experimental group, but in dorsal subcutaneous</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>thoracic sympathetic block</intervention_name>
    <description>Thoracic sympathetic block is sympathetic block of upper limb described by Leriche e Fontaine em 1925. The block is performed under radioscopic view, positioning the needle lateral the body of thoracic vertebra T3, where infuse anesthetic solution. The theoretical advantage over the stellate ganglion is its greater specificity and efficiency. Solution block: 5ml ropivacaine 0,75% + 5ml de triamcinolone 2%</description>
    <arm_group_label>thoracic sympathetic block</arm_group_label>
    <arm_group_label>control block</arm_group_label>
    <other_name>T2-T3 thoracic sympathetic block</other_name>
    <other_name>T3 sympathetic block</other_name>
    <other_name>T2-T3 thoracic dorsal sympathetic block</other_name>
    <other_name>thoracic sympathetic ganglion block</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Complex regional pain syndrome (IASP, 1994) involving an upper limb;

          -  Pain scores in excess of five visual analog scale (VAS);

          -  Poor outcome to treatment (less than 50% reduction in VAS scores) -

        Exclusion Criteria:

          -  History of severe brain injury, epilepsy and stroke

          -  Patients who had undergone sympathetic ganglion block for treatment of the affected
             limb, by any technique

          -  Severe systemic disease

          -  Addictive behavior, severe psychiatric disorders, psychiatric diseases untreated

          -  Refusal to participate or not initial adherence to orientations

          -  Refusal to be randomized in a treatment group or with contraindications to any of them
             pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roberto O Rocha, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital das Clinicas Faculty of Medicine University Sao Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roberto O Rocha, MD</last_name>
    <phone>551182668553</phone>
    <email>contato@drrobertorocha.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital das Clinicas, Faculty of Medicine, University of Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto O Rocha, MD</last_name>
      <phone>5511 82668553</phone>
      <email>contato@drrobertorocha.com.br</email>
    </contact>
    <investigator>
      <last_name>Roberto O Rocha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 30, 2012</study_first_submitted>
  <study_first_submitted_qc>June 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2012</study_first_posted>
  <last_update_submitted>June 1, 2012</last_update_submitted>
  <last_update_submitted_qc>June 1, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Roberto O Rocha</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>CRPS I</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Somatoform Disorders</mesh_term>
    <mesh_term>Complex Regional Pain Syndromes</mesh_term>
    <mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

